Taysha Gene Therapies Inc (TSHA) — Working Capital to Net Assets Ratio
Taysha Gene Therapies Inc (TSHA) has a Working Capital to Net Assets ratio of 123.7% as of March 2026. Working capital of $262.15 Million (current assets of $282.25 Million minus current liabilities of $20.10 Million) is measured against net assets of $211.94 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial agility of Taysha Gene Therapies Inc to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Taysha Gene Therapies Inc Working Capital to Net Assets (2019–2025)
This chart shows how Taysha Gene Therapies Inc's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 123.7%, reflecting working capital of $262.15 Million against net assets of $211.94 Million USD. See TSHA net asset quality score to measure how much of total assets are equity-financed.
Annual Working Capital to Net Assets for Taysha Gene Therapies Inc (2019–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Taysha Gene Therapies Inc from 2019 to 2025, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Taysha Gene Therapies Inc stock valuation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 120.7% | $298.10 Million | $246.94 Million | $324.65 Million | $26.55 Million | ▼ -41.3 pp |
| 2024 | 162.0% | $115.90 Million | $71.53 Million | $142.13 Million | $26.23 Million | ▲ +11.1 pp |
| 2023 | 150.9% | $113.11 Million | $74.94 Million | $149.87 Million | $36.76 Million | ▼ -3392.5 pp |
| 2022 | 3543.4% | $33.63 Million | $949.00K | $96.42 Million | $62.79 Million | ▲ +3430.3 pp |
| 2021 | 113.1% | $107.86 Million | $95.38 Million | $159.60 Million | $51.75 Million | ▲ +13.3 pp |
| 2020 | 99.8% | $250.75 Million | $251.30 Million | $257.88 Million | $7.13 Million | ▼ -0.2 pp |
| 2019 | 100.0% | $-135.00K | $-135.00K | $15.00K | $150.00K | — |